Showing results (351-360 of 371) with videos related to

Sort By:
Pageof 38
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 18, 2003
Randomised, multicentre phase II study assessing two doses of docetaxel (75 or 100 mg/m2) as second-line monotherapy for non-small-cell lung cancerE Quoix, B Lebeau, A Depierre, et al.
Cancer Biomarkers : Section a of Disease Markers|March 13, 2008
Complete mutation screening and haplotype characterization of BRCA1 gene in Tunisian patients with familial breast cancerW Troudi, N Uhrhammer, K Ben Romdhane, et al.
European Journal of Cancer (Oxford, England : 1990)|October 14, 2009
Comparison of dysplasia profiles in stimulated ovaries and in those with a genetic risk for ovarian cancerJ Dauplat, G Chene, C Pomel, et al.
Revue Des Maladies Respiratoires|December 29, 2000
[Evaluation of occupational exposures in lung cancer]K Legrand Cattan, C Chouaïd, I Monnet, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 24, 1997
Long-term survivors of small-cell lung cancer (SCLC): a French multicenter study. Groupe d'Oncologie de Langue FrançaiseP Jacoulet, A Depierre, D Moro, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 3, 2005
Gemcitabine-docetaxel versus cisplatin-vinorelbine in advanced or metastatic non-small-cell lung cancer: a phase III study addressing the case for cisplatinJ-L Pujol, J-L Breton, R Gervais, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 18, 1999
Topotecan versus cyclophosphamide, doxorubicin, and vincristine for the treatment of recurrent small-cell lung cancerJ von Pawel, J H Schiller, F A Shepherd, et al.
Genes, Chromosomes & Cancer|March 1, 1997
Loss of heterozygosity at 7q31 in breast cancer: results from an International Collaborative Study Group. The Breast Cancer Somatic Genetics ConsortiumP Devilee, J Hermans, J Eyfjörd, et al.
European Journal of Cancer (Oxford, England : 1990)|January 29, 2013
Long term improved quality of life by a 2-week group physical and educational intervention shortly after breast cancer chemotherapy completion. Results of the 'Programme of Accompanying women after breast Cancer treatment completion in Thermal resorts' (PACThe) randomised clinical trial of 251 patientsF Kwiatkowski, M A Mouret-Reynier, M Duclos, et al.
Revue Des Maladies Respiratoires|May 24, 2007
[IFCT-0302 trial: randomised study comparing two follow-up schedules in completely resected non-small cell lung cancer]V Westeel, M P Lebitasy, M Mercier, et al.
Pageof 38